go-v.orgdoi

Effects of perioperative Eicosapentaenoic acid-enriched oral nutritional supplement on lean body mass after total gastrectomy for gastric cancer

Toru Aoyama, Takaki Yoshikawa, Satoshi Ida, Haruhiko Cho, Kentaro Sakamaki, Yuichi Ito, Kazumasa Fujitani, Nobuhiro Takiguchi, Yoshiyuki Kawashima, Kazuhiro Nishikawa, Takashi Oshima, Souya Nunobe, Naoki Hiki · Journal of Cancer · 2019

  • DOI 10.7150/jca.29632
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2019

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2019

Abstract

Background: In previous our phase III study to compare perioperative standard diet with or without Eicosapentaenoic acid (EPA)-enriched oral nutritional supplement (EPA-ON), additional EPA-ON did not contribute to prevent body weight loss after total gastrectomy.This report clarified whether EPA-ON could prevent loss of lean body mass (LBM) after total gastrectomy, a key secondary endpoint, in our phase III trial.Methods: This phase III study was designed as multicenter, open-label, superiority, randomized trial to confirm the preventive effect of EPA-ON body weight loss after total gastrectomy for gastric cancer.Eligible patients were randomized to either Standard-diet group or EPA-ON group by a centralized dynamic method.Standard-diet group was given no additional nutritional supplementation perioperatively (standard diet), while EPA-ON group was given an EPA-enriched supplement (ProSure ® , Abbott Japan, Tokyo, Japan) in addition to their standard diet.This supplement included 600 kcal with 2.2 g/day of EPA.For both groups, patients underwent total gastrectomy with Roux-en Y reconstruction.Results: A total of 123 patients (Group A: 60, Group B: 63) were analyzed in the study.All background factors were well balanced between the both groups.Median loss of LBM was 6.74% (range -3.91% to 20.27%) in the Standard-diet group and 6.89% (range -5.11% to 20.04%) in the EPA-ON group at 1 month after surgery and was 8.59% (range -4.40% to 20.27%) in the Standard-diet group and 7.77% (range -5.57% to 23.35%) in the EPA-ON group at 3 months after surgery, which was not significantly different at the both (p=0.794 and p=0.393, respectively).Conclusions: The perioperative EPA-ON could not be recommended to prevent loss of LBM after total gastrectomy.

Open the resolved locator · 10.7150/jca.29632

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 21:14 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v10p1070.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.